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Streptococcus agalactiae, or group B streptococcus (GBS), is an important pathogen in neonates ([@B1][@B2][@B3]), with early infections being acquired from the maternal genitourinary tract ([@B4]). In addition, GBS is now recognized as an increasingly important pathogen among immunosuppressed and elderly individuals in high-income regions ([@B5], [@B6]).

GBS expresses a capsular polysaccharide that is involved in virulence and immune evasion. Ten different serotype variants (i.e., Ia, Ib, II, III, IV, V VI, VII, VIII, and IX), which differ in their disease-causing abilities, have been described. Conjugate vaccines targeting the most common disease-causing serotypes are currently in development ([@B7]). Establishment of vaccine serotype coverage is important, as is postintroduction surveillance to monitor for potential serotype replacement, as has been seen following the introduction of other conjugate vaccines ([@B8]).

Current methods for GBS serotype allocation rely on latex agglutination assays or PCR assays ([@B9]). Recent advances in whole-genome sequencing (WGS) have enabled the development of approaches that can be used in place of traditional microbiological methods, such as strain typing and antibiotic susceptibility profiling ([@B10][@B11][@B12]). A major advantage of this approach is that the cost of sequencing can be mitigated by the ability to use the same data to generate multiple outputs. Given the decreasing cost of WGS ([@B13]) and the ongoing increase in WGS data generation, we sought to establish and to validate a WGS-based method for GBS capsular typing.

We developed an algorithm for serotype assignment on the basis of sequence similarity between a given *de novo* assembly and capsular gene sequences of the 10 GBS serotypes. For nine serotypes, published sequences were used as references ([Table 1](#T1){ref-type="table"}); for serotype IX, however, only a partial capsular locus sequence has been published ([@B14]). A suitable reference for the full capsular locus region was therefore determined by WGS of a serotype IX isolate obtained from the Statens Serum Institute (Copenhagen, Denmark).

###### 

Reference sequences used for sequence-based serotype allocation

  Serotype   GenBank accession no.                   Region (bp)   Reference
  ---------- --------------------------------------- ------------- ----------------------------
  Ia         [AB028896.2](AB028896.2)                6982--11695   Yamamoto et al. ([@B20])
  Ib         [AB050723.1](AB050723.1)                2264--6880    Watanabe et al. ([@B21])
  II         [EF990365.1](EF990365.1)                1915--8221    Martins et al. ([@B22])
  III        [AF163833.1](AF163833.1)                6592--11193   Chaffin et al. ([@B23])
  IV         [AF355776.1](AF355776.1)                6417--11656   Cieslewicz et al. ([@B24])
  V          [AF349539.1](AF349539.1)                6400--12547   Cieslewicz et al. ([@B24])
  VI         [AF337958.1](AF337958.1)                6437--10913   Cieslewicz et al. ([@B24])
  VII        [AY376403.1](AY376403.1)                3403--8666    Cieslewicz et al. ([@B24])
  VIII       [AY375363.1](AY375363.1)                2971--7340    Cieslewicz et al. ([@B24])
  IX         NA[^*a*^](#T1F1){ref-type="table-fn"}   NA            This study

NA, not applicable.

To assign the serotype for a given isolate, a BLAST database was generated from the *de novo* assembly and queried with the variable region of the capsular locus sequence for each serotype (*cpsG-cpsK* for serotypes Ia to VII and IX and *cpsR-cpsK* for serotype VIII), using BLASTn with an E value threshold of 1e−100 and otherwise default parameters. A serotype was considered correct if it showed ≥95% sequence identity over ≥90% of the sequence length. These thresholds were chosen on the basis of being stringent enough to provide differentiation between the various reference sequences while maximizing serotype allocation for an initial test set of publicly available GBS WGS data, for which serotype information was not available (therefore, we had no way of knowing whether the assigned serotypes were actually correct).

This sequence-based method for serotype allocation was validated using WGS with a set of 223 colonizing or invasive human isolates from Canada, Latin America, Singapore, the United Kingdom, the United States, and Thailand for which serotypes had been determined previously using conventional latex agglutination assays, with PCR assays being used to confirm weak positive or negative results in a subset ([@B15][@B16][@B17]). For two rare serotypes (serotypes VIII and IX), one isolate of each was obtained from the Statens Serum Institute. GBS isolates stored at −80°C were subcultured on Columbia blood agar for 24 to 48 h, followed by DNA extraction from a single colony using a commercial kit (QuickGene; Fujifilm, Tokyo, Japan). High-throughput sequencing was performed at the Wellcome Trust Centre for Human Genetics (Oxford University, Oxford, United Kingdom) using the Illumina HiSeq2500 platform, generating 150-base paired-end reads. *De novo* assembly was performed using Velvet and VelvetOptimiser ([@B18], [@B19]). Agreement between serotype allocations was tested with the kappa statistic.

High-quality sequence data were obtained for all 223 GBS isolates (median read number, 2,975,508 \[range, 1,798,744 to 13,073,718\]; median contig number, 46 \[range, 16 to 106\]; median assembly length, 2.05 Mb \[range, 1.94 to 2.22 Mb\]). Each isolate was allocated to a single serotype using the WGS data ([Table 2](#T2){ref-type="table"}). Three isolates that did not have a capsular type assigned by latex agglutination methods had serotypes Ib, VI, and VII assigned. For all previously serotyped GBS isolates with a known capsule type, the kappa statistic of 0.92 indicated very strong agreement between WGS-predicted and conventional serotypes. Nine isolates had discordant results. In each case, there was strong support for the sequence-allocated serotype, with \>98% sequence identity over 100% of the reference length in all nine cases ([Fig. 1](#F1){ref-type="fig"}). Across all isolates, differences in relatedness between the capsular locus sequences of the different serotypes led to characteristic relationships between the allocated serotype (best match) and the second-best match. For example, all isolates assigned to serotype Ia had serotype III as the second-best match. In all cases, the second-best match was substantially poorer than the best match, demonstrating that there was no ambiguity in the predicted serotype ([Fig. 1](#F1){ref-type="fig"} and [Table 3](#T3){ref-type="table"}).

###### 

Serotype allocation by WGS versus serotype allocation by latex agglutination

  Latex agglutination serotype   No. with WGS serotype of:   Total no.                                                                                                              
  ------------------------------ --------------------------- ----------- ---- ----- --- ---- ---- --- -------------------------------------- -------------------------------------- -----
  Ia                             34                          0           0    1     0   0    0    0   0                                      0                                      35
  Ib                             0                           9           1    0     0   0    0    0   0                                      0                                      10
  II                             0                           0           25   0     0   0    0    0   0                                      0                                      25
  III                            3                           0           0    111   0   0    0    0   0                                      1                                      115
  IV                             0                           0           0    0     1   0    1    0   0                                      0                                      2
  V                              0                           0           0    0     0   16   0    0   0                                      0                                      16
  VI                             0                           0           0    0     0   1    8    0   0                                      0                                      9
  VII                            0                           0           0    0     0   0    0    5   0                                      0                                      5
  VIII                           0                           0           0    0     0   0    0    0   1[^*a*^](#T2F1){ref-type="table-fn"}   0                                      1
  IX                             0                           1           0    0     0   0    0    0   0                                      1[^*a*^](#T2F1){ref-type="table-fn"}   2
  Nontypeable                    0                           1           0    0     0   0    1    1   0                                      0                                      3
  Total                          37                          11          26   112   1   17   10   6   1                                      2                                      223

Reference GBS isolates from Statens Serum Institute for serotypes VIII and IX.

![Relationships between allocated serotypes (best matches) and second-best matches. For each isolate, the percentage of the capsular locus region present (≥95% sequence identity) for the assigned serotype is shown on the *x* axis and that for the serotype showing the next best match is shown on the *y* axis. Gray circles, isolates showing agreement between sequence-based serotyping and conventional serotyping; blue circles, isolates classified as nontypeable by conventional methods; red circles, isolates with discordant results. Small circles, single isolates; large circle, 100 isolates. For each serotype, the second-best match is identical in all cases, leading to the observed horizontal banding (details in [Table 3](#T3){ref-type="table"}).](zjm9990949490001){#F1}

###### 

Relationships between allocated serotypes and second-best matches[^*a*^](#T3F1){ref-type="table-fn"}

  Allocated serotype   Match (%) for allocated serotype   Second-best serotype   Match (%) for second-best serotype
  -------------------- ---------------------------------- ---------------------- ------------------------------------
  Ia                   93.91--100                         III                    64.56
  III                  100                                Ia                     62.98
  V                    100                                IX                     36.26
  IX                   100                                V                      31.05
  VI                   100                                III                    26.68
  IV                   100                                Ia                     20.3
  Ib                   99.61--100                         VI                     15.55
  II                   99.86--100                         IV                     9.45
  VII                  100                                Ib                     6.95
  VIII                 100                                None                   0

See also [Fig. 1](#F1){ref-type="fig"}.

The nine isolates with discordant results and the three nontypeable isolates were retested by latex agglutination assays ([Table 4](#T4){ref-type="table"}) and were resequenced using the Illumina MiSeq platform, with sequence processing and WGS-based serotype prediction performed as described above. In all cases, resequencing results were consistent with the initial WGS classification. For 6/9 isolates with discordant results, the new latex agglutination results matched the WGS-based prediction, suggesting that the initial discordance might have resulted from incorrect latex agglutination typing or sample mislabeling. The other three isolates with discordant results and the three nontypeable isolates were all classified as nontypeable with retesting.

###### 

Retyping of isolates with discordant results and nontypeable isolates

  Isolate   Reason for retyping   Latex agglutination serotype   WGS serotype                                  
  --------- --------------------- ------------------------------ --------------------------------------- ----- -----
  CB466     Discordant results    III                            Ia                                      Ia    Ia
  IW8194    Discordant results    III                            IX                                      IX    IX
  IW8466    Discordant results    Ia                             III                                     III   III
  IW8471    Discordant results    III                            Ia                                      Ia    Ia
  IW7157    Discordant results    Ib                             II                                      II    II
  SMRU1     Discordant results    VI                             V                                       V     V
  SMRU25    Discordant results    IV                             NT[^*a*^](#T4F1){ref-type="table-fn"}   VI    VI
  SMRU4     Discordant results    IX                             NT                                      Ib    Ib
  SMRU59    Discordant results    III                            NT                                      Ia    Ia
  Z41       NT                    NT                             NT                                      Ib    Ib
  UK22      NT                    NT                             NT                                      VII   VII
  IW2723    NT                    NT                             NT                                      VI    VI
  CB454     Control               III                            III                                     III   III
  IW4445    Control               Ia                             Ia                                      Ia    Ia
  IW4077    Control               II                             II                                      II    II

NT, nontypeable.

This WGS-based method for GBS serotyping, which was validated using 223 isolates that had been typed using conventional methods, was therefore highly accurate. Although WGS currently may not be cost-effective for direct replacement of traditional serotyping, costs are likely to decrease further. Furthermore, WGS may already be the cheapest option for combined studies, with possibilities for utilizing the resulting data for additional analyses, such as multilocus sequence typing, analyses of relatedness to other sequenced isolates, and detailed phylogenetic analyses.
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